News
Entertainment
Science & Technology
Sport
Business & Money
Life
Culture & Art
Hobbies
6 | Follower
Hospital Pharmacy Europe
22.10.2025
The opioid painkiller tramadol has only a limited effect on... Read more
21.10.2025
The addition of aspirin to the treatment of high-risk patients... Read more
18.10.2025
Despite the increasing use of PARP inhibitors in treating several... Read more
17.10.2025
Explore the latest advances in respiratory infection management at Clinical Excellence in Respiratory Care – registration is now open.
A new study reveals the promise of base-edited donor CAR T-cell therapies in treating relapsed or refractory AML.
16.10.2025
Early aspirin discontinuation and transition to a P2Y12 inhibitor monotherapy... Read more
A combination reliever inhaler containing an inhaled corticosteroid significantly reduces... Read more
Pharmacogenomics is becoming a clinical reality and João Gonçalves proposes a pharmacy-led PGx model and explains how to implement it.
10.10.2025
Amy Mundell explores the critical role of pharmacy in shared decision-making around polypharmacy and deprescribing in palliative care.
The investigational, highly selective aldosterone synthase inhibitor baxdrostat has shown... Read more
Hospital Pharmacy Europe is recruiting key healthcare professionals to specialist focus groups on automated unit-dose dispensing systems.
02.10.2025
Charlotte D’haene and Dr Robert Leach explain how pharmacist integration in the ED is being put into practice at their hospital.
The cardiac glycoside digitoxin, derived from digitalis purpurea, can reduce... Read more
25.09.2025
A new study highlights entrenched polypharmacy in managing heart failure and calls for multidisciplinary strategies to optimise care.
Digital communication is reshaping clinical pharmacy practice in Denmark's Region Zealand, say Mia Pavelics Rehn and Trine R. H. Andersen.
Pharmacist consultations have a positive impact on patient knowledge and safety in biologic DMARD therapy for chronic inflammatory arthritis.
18.09.2025
The role of beta-blockers after myocardial infarction (MI) in patients... Read more
11.09.2025
Medicines containing fluorine – a type of per- and polyfluoroalkyl... Read more
The next frontier of personalised medicine is microrobots, so what's being done to unlock the potential of this precise, safe drug delivery?
Increasing plasma potassium levels to the high-normal range can improve... Read more
06.09.2025
Ethnicity may significantly affect how patients respond to hypertension medication,... Read more
04.09.2025
In this commentary from the Respiratory Effectiveness Group (REG), Professor... Read more
The potential for AI to optimise efficiency, safety and personalised care in pharmacy is the subject of a new policy statement from FIP.
02.09.2025
A new treatment hailed as ‘one of the most significant... Read more
Hospital pharmacists have a vital role in progressing antimicrobial stewardship as part of the multidisciplinary team – but where to start?
25.08.2025
Patients taking prescribed psychotropic medications, such as antidepressants and mood... Read more
Patient prioritisation systems are beneficial for pharmacy teams working in mental health settings and can support overstretched services.
Read about the new DIAMOND programme using real-world data to support deprescribing and how pharmacists can help to tackle polypharmacy.
Patients with psoriasis who show an early response to treatment... Read more
12.08.2025
Michael Wilcock and Ersa Tsoutsoura present further analysis of dupilumab and JAK inhibitor prescribing for atopic dermatitis.
08.08.2025
Alan Timmins discusses the complexities of licensed ready-to-use and ready-to-administer IV products and putting a price on safety.
Adam Sutherland discusses what the NHS is doing to support IV safety, what's in the pipeline and how pharmacists can play their part.
Alistair Gray shares the latest insights from a fluid stewardship programme implemented at East Lancashire Hospitals NHS Trust.
Better integration and coordination between care settings will improve medication support around hospital discharge for people with COPD.
Dr Philip Barclay discusses the transition to NRFit, where we are now and what can be done to manage patient safety risks.
Andrew Barton discusses the complications of IV therapy and the latest guidelines and recommendations for preventing and managing them.
Matthias Hellberg-Naegele considers the joint responsibility of pharmacists and nurses to enhance occupational safety around hazardous drugs.
A new study highlights the risks of atopic dermatitis flare-ups... Read more
Alan Timmins shares his take on the essentials of intravenous fluids at Hospital Pharmacy Europe’s Virtual Study Day on IV medicines safety.
ESCMID Global 2025 explored how AI is supporting infectious disease management, as well as the associated risks and future directions.